Sotera Health (NASDAQ:SHC – Get Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Sotera Health to post earnings of $0.21 per share and revenue of $291.37 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Sotera Health Trading Up 1.9 %
SHC opened at $13.73 on Wednesday. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The company has a market cap of $3.89 billion, a P/E ratio of 54.92 and a beta of 1.91. The company has a fifty day moving average price of $13.48 and a two-hundred day moving average price of $14.54. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.
Analyst Upgrades and Downgrades
SHC has been the subject of several recent research reports. Barclays decreased their price objective on Sotera Health from $18.00 to $17.00 and set an “overweight” rating for the company in a report on Tuesday, February 18th. The Goldman Sachs Group assumed coverage on Sotera Health in a report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Finally, Citigroup lifted their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.08.
About Sotera Health
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Further Reading
- Five stocks we like better than Sotera Health
- How Technical Indicators Can Help You Find Oversold Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- What is a Dividend King?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Where to Find Earnings Call Transcripts
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.